Testing effectiveness (Phase 2)Study completedNCT01252810
What this trial is testing
Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure
Who this might be right for
Chronic Renal InsufficiencyDiabete MellitusCongestive Heart Failure
GE Healthcare 284